Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huo Xue Jie Du Tang (HXJDT) is a Traditional Chinese Medicine (TCM) decoction developed by the China-Japan Friendship Hospital, specifically for the treatment of plaque psoriasis (psoriasis vulgaris). The formula is designed based on the TCM theory of blood stasis and toxin-heat, aiming to promote blood circulation and clear heat-toxins. It typically contains a combination of herbs such as *Radix Rehmanniae*, *Rhizoma Smilacis Glabrae*, *Radix Salviae Miltiorrhizae*, and *Radix Paeoniae Rubra*. Research suggests it modulates the immune response by inhibiting the IL-23/IL-17 axis, reducing the expression of inflammatory cytokines like TNF-α and IL-6, and regulating the proliferation and differentiation of keratinocytes. It is primarily used as a hospital-made preparation in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huo Xue Jie Du Tang.